2 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
Follow Progressive Multifocal Leukoencephalopathy: new trials by email Literature Review of Progressive Multifocal Leukoencephalopathy trials Research Report on Progressive Multifocal Leukoencephalopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Study Evaluating JCPyV-specific T Cell Therapy for PML CE-VST01-JC - Progressive Multifocal Leukoencephalopathy | Phase 2 | Unknown | Cellevolve Bio Inc | 60 | 2023-02-01 | 2022-09-16 |
| Treatment of PD-1 Inhibitor in AIDS-associated PML Pembrolizumab - Progressive Multifocal Leukoencephalopathy, AIDS | Phase 2 | Unknown | First Affiliated Hospital of Zhejiang University | 10 | 2019-08-20 | 2019-09-20 |
Leukoencephalopathy, Progressive Multifocal (2) · Acquired Immunodeficiency Syndrome (1)
Brain Diseases (2) · Central Nervous System Diseases (2) · Central Nervous System Infections (2) · Central Nervous System Viral Diseases (2) · DNA Virus Infections (2) · Demyelinating Diseases (2) · Encephalitis (2) · Encephalitis, Viral (2) · Infections (2) · Infectious Encephalitis (2) · Leukoencephalopathies (2) · Nervous System Diseases (2) · Neuroinflammatory Diseases (2) · Polyomavirus Infections (2) · Slow Virus Diseases (2)
Immune Checkpoint Inhibitors (1) · pembrolizumab (1)
Cellevolve Bio Inc (1) · First Affiliated Hospital of Zhejiang University (1)
China (1)
Biao Zhu, PhD (1)